HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
Trial details
- Registry ID
- NCT00877656
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| HuMax-CD4 in Non-Cutaneous T-Cell LymphomaNCT00877656 | Emergent BioSolutions | Phase 2, Phase 3 | Completed | 2006-01Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |